![]() AmacaThera AmacaThera is a biotechnology company focused on developing and commercializing an injectable hydrogel platform technology for a wide range of medical applications. | ![]() Velabs Therapeutics Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies. | ![]() Waypoint Bio Waypoint Bio is a biotech company that develops cell therapies for solid tumors and autoimmune diseases. | ![]() Fauna Bio Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans. | ![]() Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. | |
Founding Date | Founding Date 2016 | Founding Date N/A | Founding Date 2021 | Founding Date 2018 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Toronto, CA HQ Toronto, CA | Locations Heidelberg, DE HQ | Locations New York, US HQ New York, US | Locations Emeryville, US HQ Berkeley, US | Locations New York, US HQ |
Employees | Employees 12 | Employees N/A | Employees 157% increase | Employees 28 | Employees 524% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 3.6m (over 6 years ago) | Latest funding round $ 3.4m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 4.1m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 6.1m | Total funding raised $ 3.4m | Total funding raised N/A | Total funding raised $ 4.1m | Total funding raised N/A |

Velabs Therapeutics is a pioneer in microfluidics-based technologies for functional screening of antibodies.
View company
Waypoint Bio is a biotech company that develops cell therapies for solid tumors and autoimmune diseases.
View company
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
View company
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View company